Folic acid reduces risk of neural tube defects linked to HIV drug dolutegravir
Dolutegravir is a preferred medication for treating HIV infection, but it recently has been linked to a 6- to 9-fold increase in the risk for neural tube defects among babies born to mothers receiving the drug during early ...
Jul 24, 2019
0
1